Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| OpGen Inc | OPGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.563 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.563 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.165 - 3.84 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.563 | USD |
OpGen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.61M | 10.01M | - | 2.61M | -37.28M | -3.72 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
OpGen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OPGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.585 | 0.63 | 0.555 | 0.5996793 | 122,224 | -0.022 | -3.76% |
| 1 Month | 0.67 | 0.84 | 0.555 | 0.6711401 | 643,025 | -0.107 | -15.97% |
| 3 Months | 0.3488 | 0.99 | 0.30 | 0.7065526 | 1,824,771 | 0.2142 | 61.41% |
| 6 Months | 0.6529 | 0.99 | 0.24 | 0.6752423 | 999,044 | -0.0899 | -13.77% |
| 1 Year | 0.95 | 3.84 | 0.165 | 0.6684168 | 1,698,328 | -0.387 | -40.74% |
| 3 Years | 43.20 | 74.40 | 0.165 | 14.37 | 1,496,960 | -42.64 | -98.70% |
| 5 Years | 10.80 | 256.00 | 0.165 | 38.29 | 2,132,980 | -10.24 | -94.79% |
OpGen Description
| OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base. |
